Lipid lowering agents

17
Lipid lowering agents By: Dr Israa Omar MBBS, MRCP, MSc pharmacology

description

Lipid lowering agents. By: Dr Israa Omar MBBS, MRCP, MSc pharmacology. HMG-CoA reductase inhibitors. Reduces plasma concentration of LDL- Cholestrol by more than 30%. Also cause a small reduction on plasma TGA and a small increase in plasma HDL - PowerPoint PPT Presentation

Transcript of Lipid lowering agents

Page 1: Lipid lowering agents

Lipid lowering agentsBy: Dr Israa Omar

MBBS, MRCP, MSc pharmacology

Page 2: Lipid lowering agents

Reduces plasma concentration of LDL-Cholestrol by more than 30%.

Also cause a small reduction on plasma TGA and a small increase in plasma HDL

(statins)include simvastatin, pravastatin, atorvastatin.

REDUCE THE RISK OF CORONARY RTERY DISEASE BY 42%

HMG-CoA reductase inhibitors

Page 3: Lipid lowering agents

Suppress HMG-COA reductase in the liver and therefore depress the production of cholesterol, which leads to increase synthesis of LDL receptors .

As a result, the clearance of LDL is enhanced

MOA

Page 4: Lipid lowering agents

To treat patient with hyperlipidemia

Clinical uses

Page 5: Lipid lowering agents

GIT disturbance Insomnia Rash More serious adverse effects (myositis,

hepatitis, angio-oedema )

Adverse effects

Page 6: Lipid lowering agents

Include clofibrate, gemofibrate, fenofibrate. Mainly reduce VLDL and hence triglyceride . Also reduce LDL and increase HDL Gemofibrozil has been shown to reduce

coronary heart disease by one third compared to the placebo in male patients with primary hyperlipidaemia

fibrates

Page 7: Lipid lowering agents

Stimulate the lipoprotien lipase in the peripheral tissues, and hence, increase hydrolysis of TGA in chylomicron and VLDL particles.

Also probably reduce hepatic VLDL production and increase LDL uptake

MOA

Page 8: Lipid lowering agents

To treat patients with mixed hyperlipidemia (raised TGA and raised cholestrol)

Clinical uses

Page 9: Lipid lowering agents

Myositis which can cause myoglobinuria and acute renal failure

Clofibrate can cause gallstone so its use is limited to patients who have had cholcystomy

Adverse effects

Page 10: Lipid lowering agents

Cholestyramine and Colestipol They reduce the plasma concentration of

LDL-cholestrol by more than 10%

Bile acid-binding resins

Page 11: Lipid lowering agents

They sequester the bile in the intestine and prevent their reabsorption and entero-hepatic recirculation.

This lead to increase expression of LDL receptors in the liver and hence removal of LDL from the blood

MOA

Page 12: Lipid lowering agents

Used in addition to statins to treat hyperlipidemia

Clinical uses

Page 13: Lipid lowering agents

N/V, abdominal pain , bloating, constipation or diarrhea are the commonest adverse effects

They interfere with absorption of fat- soluble vitamins and drugs like Digoxin and Warfarin

Adverse effect

Page 14: Lipid lowering agents

Mechanism of action is poorly understood It is a water soluble vitamin Inhibit the production of hepatic triglyceride

and VLDL secretion with reduction of in TGA and LDL and increase HDL

It increase the blood sugar and causes flushing of the face an effect that can be reduced by taking Aspirin

Modified release prepartion are well tolerated

Nicotinic acid derivatives

Page 15: Lipid lowering agents

Specifically inhibits absorption of cholesterol by blocking NPC1L1 in the brush border without affecting the absorption of bile salts or fat soluble vitamins

Combined with statins to treat patients with severe dyslipidemia

Generally well tolerated but can cause diarrhea, headache, rash and angioedema also reported

Ezetimibe

Page 16: Lipid lowering agents

Thank you

Page 17: Lipid lowering agents

RANGE AND DALE ,PHARMACOLOGY

Reference